These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 10027587)

  • 1. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
    Scribner KA; Gadbois TM; Gowri M; Azhar S; Reaven GM
    Metabolism; 2000 Sep; 49(9):1106-10. PubMed ID: 11016888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
    Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
    Gao L; Niu Y; Liu W; Xie M; Liu X; Chen Z; Li L
    Clin Chim Acta; 2008 Feb; 388(1-2):89-94. PubMed ID: 17991430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
    Zhang XF; Tan BK
    Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
    Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
    Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
    Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
    Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
    Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
    Nagi DK; Ali VM; Yudkin JS
    Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
    Gad MZ; Ehssan NA; Ghiet MH; Wahman LF
    Pak J Pharm Sci; 2010 Jul; 23(3):305-12. PubMed ID: 20566445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of new hypoglycemic agent A-4166 on lipolysis and lipogenesis in rat adipocytes.
    Macho L; Fickova M; Zorad S; Sebokova E; Klimes I
    Endocr Regul; 2000 Sep; 34(3):119-26. PubMed ID: 11074662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
    J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.